[HTML][HTML] Determinants and predictors for the long-term disease burden of intracranial meningioma patients
AH Zamanipoor Najafabadi, PB van der Meer… - Journal of Neuro …, 2021 - Springer
Introduction Meningioma is a heterogeneous disease and patients may suffer from long-term
tumor-and treatment-related sequelae. To help identify patients at risk for these late effects …
tumor-and treatment-related sequelae. To help identify patients at risk for these late effects …
Determinants and predictors for the long-term disease burden of intracranial meningioma patients.
ZN AH, PB van der Meer, FW Boele… - Journal of Neuro …, 2020 - europepmc.org
Methods Secondary data analysis of a cross-sectional multicenter study with intracranial
WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive …
WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive …
Determinants and predictors for the long-term disease burden of intracranial meningioma patients
B van der Meer Pim, FW Boele, TM JB… - Journal of Neuro …, 2021 - search.proquest.com
Methods Secondary data analysis of a cross-sectional multicenter study with intracranial
WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive …
WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive …
[HTML][HTML] Determinants and predictors for the long-term disease burden of intracranial meningioma patients
AHZ Najafabadi, PB van der Meer… - Journal of Neuro …, 2021 - ncbi.nlm.nih.gov
Methods Secondary data analysis of a cross-sectional multicenter study with intracranial
WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive …
WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive …
[PDF][PDF] Determinants and predictors for the long‑term disease burden of intracranial meningioma patients
AHZ Najafabadi, PB van der Meer… - Journal of Neuro …, 2021 - scholar.archive.org
Introduction Meningioma is a heterogeneous disease and patients may suffer from long-term
tumor-and treatment-related sequelae. To help identify patients at risk for these late effects …
tumor-and treatment-related sequelae. To help identify patients at risk for these late effects …
Determinants and predictors for the long-term disease burden of intracranial meningioma patients
AHZ Najafabadi, PB van der Meer… - Journal of neuro …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Meningioma is a heterogeneous disease and patients may suffer from long-term
tumor-and treatment-related sequelae. To help identify patients at risk for these late effects …
tumor-and treatment-related sequelae. To help identify patients at risk for these late effects …
[PDF][PDF] determinants and predictors of the long-term disease burden in meningioma
AHZ Najafabadi… - Journal of …, 2021 - scholarlypublications …
Methods Secondary data analysis of a cross-sectional multicenter study with intracranial
WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive …
WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive …
Determinants and predictors for the long-term disease burden of intracranial meningioma patients.
AH Zamanipoor Najafabadi… - Journal of Neuro …, 2021 - search.ebscohost.com
Introduction: Meningioma is a heterogeneous disease and patients may suffer from long-
term tumor-and treatment-related sequelae. To help identify patients at risk for these late …
term tumor-and treatment-related sequelae. To help identify patients at risk for these late …
[PDF][PDF] Determinants and predictors for the long‑term disease burden of intracranial meningioma patients
AHZ Najafabadi… - Journal of …, 2021 - scholarlypublications …
Introduction Meningioma is a heterogeneous disease and patients may suffer from long-term
tumor-and treatment-related sequelae. To help identify patients at risk for these late effects …
tumor-and treatment-related sequelae. To help identify patients at risk for these late effects …